Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) [Phase 4]
Phase 4 trial evaluating mirabegron for overactive bladder symptoms in men taking tamsulosin for lower urinary tract symptoms due to benign …
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Fesoterodine on Urgency Episodes in Parkinson's Disease Population [Phase 4]
Phase 4 trial update on fesoterodine for urgency episodes in Parkinson's disease; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children [Phase 3]
Phase 3 trial update for fesoterodine and oxybutynin XR in children with overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. [Phase 3]
Extension study update for fesoterodine in children with overactive bladder, Phase 3, completed.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Lidocaine for Pain After Urodynamic Testing [Phase 4]
Phase 4 clinical trial evaluating lidocaine for pain relief following urodynamic testing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Controlling Urgency Through Relaxation Exercises [NA]
Completed clinical trial evaluating relaxation exercises to control urgency in patients with overactive bladder and urgency urinary symptoms…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder [Phase 3]
Phase 3 trial update on GSK1358820 for overactive bladder reports results and safety data.
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder. [Phase 3]
Phase 3 trial comparing imidafenacin (Uritos) to tolterodine (Urotol) for overactive bladder has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Mirabegron in Parkinson Disease and Impaired Cognition [Phase 4]
Phase 4 clinical trial update on mirabegron in Parkinson disease and impaired cognition with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction [Phase 3]
Phase 3 clinical trial of Botox for overactive bladder due to benign prostatic obstruction has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms [Phase 4]
Phase 4 trial update on the timing of belladonna and opium suppositories to relieve post-operative bladder spasms in Overactive Bladder; the…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) [Phase 4]
Phase 4 study evaluating efficacy, safety, and tolerability of mirabegron in older adults with overactive bladder has completed with results…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome [NA]
A completed clinical trial comparing different posterior tibial nerve electrical stimulation protocols for treating overactive bladder.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
Completed clinical trial from National Taiwan University Hospital examining how common nocturnal polyuria is in women with overactive bladde…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron. [Phase 4]
Phase 4 postmarketing study evaluating add-on anticholinergic therapy in patients with overactive bladder who are on mirabegron; completed w…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB [NA]
A completed clinical trial evaluating effectiveness of the NURO percutaneous tibial neuromodulation system for overactive bladder; results p…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder [NA]
Clinical trial comparing botulinum toxin A alone versus botulinum toxin A with hydrodistension for overactive bladder; study terminated with…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB) [Phase 2]
Phase 2 clinical trial evaluating intravesical botulinum toxin (Botox) for overactive bladder in women, completed.
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Reduction of Bladder Injection Pain With Belladonna Opiate Suppository [Phase 4]
Phase 4 clinical trial assessing reduction of bladder injection pain with Belladonna opiate suppository in overactive bladder and related co…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) [Phase 4]
Phase 4 study evaluating efficacy, safety, and tolerability of mirabegron in men with overactive bladder who are taking an alpha-blocker for…
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP [Phase 2]
A Phase 2 trial comparing solifenacin and mirabegron for overactive bladder symptoms in men after TURP.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women [Phase 2]
Phase 2 interventional trial in women with overactive bladder and nocturia has completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder [NA]
A clinical trial update investigating cineMRI to evaluate the effect of Botox (onabotulinumtoxinA) in patients with medication-refractory ov…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female Patients
Clinical trial comparing urodynamic measures, bladder diaries, and quality of life between women with overactive bladder who have urgency in…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder [Phase 3]
Phase 3 pilot study evaluating mirabegron for overactive bladder in pediatric patients has completed and results have been posted.